Search - tctmd.com

Displaying 21 - 40 of 66

Sort: Relevancy | Date

Presentation TCT 2019

Insights From TWILIGHT

Presenter: Usman Baber

September 26, 2019

News Daily News

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Caitlin E. Cox

September 20, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Caitlin E. Cox

March 17, 2019

News Daily News

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

L.A. McKeown

January 08, 2019

News Conference News AHA 2018

Complications Following TAVR Are Going Down, US Data Show

Yael L. Maxwell

November 20, 2018

Presentation TCT 2018

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber

September 23, 2018

News Conference News SCAI 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

Todd Neale

April 27, 2018

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

News Conference News SCAI 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

L.A. McKeown

May 12, 2017

News Daily News

Anemia Common in ACS Patients, Linked with Higher Mortality

Michael O'Riordan

November 23, 2016

Presentation TCT 2016

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, Usman Baber

November 01, 2016

Presentation TCT 2016

TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From a Large Single-Center Registry

Presenter: Neal S. Kleiman, David F. Kong, Usman Baber

October 31, 2016

Presentation TCT 2016

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Usman Baber

October 31, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

Presenter: Sorin J. Brener, Franz-Josef Neumann, Usman Baber

October 30, 2016

News Daily News

Gender Should Not Factor Into DAPT Choice After PCI

L.A. McKeown

August 19, 2016

Presentation CCVVC 2016

Timing of DAPT Interruption and DES Thrombosis

Presenter: Usman Baber

June 16, 2016

News Conference News SCAI 2016

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

L.A. McKeown

May 13, 2016

Presentation TCT 2015

Case 1: How Did We Manage This Patient?

Presenter: Paul A. Gurbel, Daniel I. Simon, Usman Baber

October 12, 2015

Advertisement

Insights From TWILIGHT

Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests

Complications Following TAVR Are Going Down, US Data Show

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Results From The BRAVO 3 Randomized Trial

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

Anemia Common in ACS Patients, Linked with Higher Mortality

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

TCT 56: Validation of PARIS Risk Scores in a Large Multi-Ethnic PCI Cohort: Results From a Large Single-Center Registry

TCT 6: Simultaneous Impact of Thrombotic and Bleeding Risks on Use of Novel P2Y12 Inhibitors in Contemporary PCI: Results From a Large Single-Center Registry

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

Gender Should Not Factor Into DAPT Choice After PCI

Timing of DAPT Interruption and DES Thrombosis

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

Case 1: How Did We Manage This Patient?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content